- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00528320
Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System
Clinical Evaluation of Cardiac Resynchronization Therapy With Implantable Cardioverter-defibrillator Therapy
This study provides a continued access registry for cardiac resynchronization therapy with defibrillation (CRT-D), which helps to resynchronize (coordinate) the rhythm of the heart by helping the left ventricle contract (pump blood) more uniformly, in patients with severe heart failure (New York Heart Association [NYHA] Class III or IV).
Quality of life, adverse events and device success will be analyzed and reported.
연구 개요
상세 설명
ICDs have been shown to increase life expectancy substantially over various drug regimens in patients with life threatening ventricular arrhythmias. Furthermore, large scale studies of cardiac resynchronization therapy in ICD-indicated heart failure patients have demonstrated improvements in functional capacity and quality of life, without unacceptable increases in morbidity or mortality.
This study provides a continued access registry for cardiac resynchronization therapy with defibrillation (CRT-D), which helps to resynchronize (coordinate) the rhythm of the heart by helping the left ventricle contract (pump blood) more uniformly, in patients with severe heart failure (NYHA Class III or IV).
Quality of life, adverse events and device success will be analyzed and reported.
연구 유형
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Accepted indication for ICD implant
- Severe heart failure (NYHA Class III or IV) at the time of enrollment
- May have pre-existing ICD, provided subject is on stable, optimal medical regime
- Sinus rhythm with spontaneous QRS duration greater than or equal to 150 ms, or a QRS duration greater than or equal to 130 ms with an inter-ventricular mechanical delay (IVMD) greater than or equal to 40 ms
- Left-ventricular ejection fraction (LVEF) of 35% or less
Exclusion Criteria:
- Any generally accepted indication for standard cardiac pacing, or any contraindication for standard cardiac pacing
- Any contraindication for ICD therapy
- Currently implanted with a lead positioned in or through the coronary sinus
- Hypertrophic or obstructive cardiomyopathy
- Acute myocarditis
- Unstable coronary symptoms (unstable angina or myocardial infarction) within the last month
- Recent or planned cardiac revascularization or coronary angioplasty
- Correctable valvular disease that is the primary cause of heart failure
- Mechanical tricuspid valve
- Chronic atrial arrhythmia or cardioversion for atrial fibrillation within the past month, or paroxysmal atrial fibrillation requiring new pharmacologic therapy within the past month
- Systolic blood pressure consistently above 170 mmHg or consistently below 80 mmHg
- Supine resting heart rate exceeding 100 bpm
- Receiving continuous IV infusion of positive inotropic therapy or intermittent therapy (IV infusion) more than twice per week
- Heart transplant recipient
- Primary pulmonary disease of a severity that might limit the patient's ability to perform a treadmill test
- Serum creatinine above 3.0 mg/dL
- Serum hepatic functions at or above three times the upper normal limit
- Cerebrovascular event within the previous three months
- Inability to walk or other physical impediments which might prevent the patient from completing a maximum, symptom-limited treadmill test
- Age of less than 18 years
- Pregnancy
공부 계획
연구는 어떻게 설계됩니까?
공동 작업자 및 조사자
연구 기록 날짜
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Ovatio CRT에 대한 임상 시험
-
Children's Hospital of PhiladelphiaThe Hilda & Preston Davis Foundation완전한
-
Inova Health Care ServicesMedtronic모집하지 않고 적극적으로왼쪽 번들-분기 블록 | 심부전(HF) | 좌심실 박출률미국
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic; Medtronic Japan Co., Ltd.완전한심부전 | 왼쪽 번들-분기 블록 | 심부전 NYHA 클래스 II | 심부전 NYHA 클래스 III | 심부전 NYHA 클래스 IV | 박출률 감소 심부전(HFrEF)대한민국, 일본, 싱가포르, 대만, 홍콩, 인도네시아, 말레이시아, 중국, 필리핀 제도, 브루나이 다루살람
-
Montreal Heart InstituteCanadian Institutes of Health Research (CIHR); Abbott Medical Devices종료됨
-
Medtronic Cardiac Rhythm and Heart Failure완전한
-
Medtronic Cardiac Rhythm and Heart Failure종료됨
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic종료됨